|
The WIRED Grant program provides funding for promising research that translates into the development of new vaccines, therapeutics, and/or diagnostics directed against NIAID Category A, B, and C agents. The funds will be used to conduct pilot studies, feasibility studies, proof-of-concept, and preliminary research for innovative, cutting-edge research in anticipation of supporting the WRCE competing continuation application that will submitted in the summer of 2008. These are highly-focused projects that are subject to yearly review, and will not be funded beyond Feb. 28, 2009. Like R21-type awards, WIRED grants are intended to encourage new,
exploratory and developmental research projects by providing support
for the early stages of their development. The main purpose of
the WIRED project awards is to promote new research in anticipation
of the WRCE competing continuation application. The Regional
|
